About the book
Lung cancer continues to be the leading cause of cancer mortality among both men and women in the world. Recent advances in prevention, screening, and management in the past decade have led to significant improvements in survival and quality-of-life. Tobacco treatment and computed tomography screening have made strides in decreasing the incidence of advanced cases. Local treatments like minimally invasive surgery (including robotic and video-assisted thoracoscopic surgery) and radiotherapy (including intensity-modulated radiotherapy and stereotactic body radiotherapy) have contributed in improving effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic disease. Chemotherapy, targeted therapy, and immunotherapy options have expanded rapidly, with new combinations showing improved outcomes even for those with polymetastatic disease. Finally, palliative care has shown a survival benefit when instituted early in the course of metastatic lung cancer management.
This book will comprehensively review the evidence that has driven personalized medicine from a variety of multidisciplinary perspectives by lung cancer experts.